Applications: |
Immunodepletion/Immunocompetition |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
SLC9A3 Blocking Peptide for STJ506227 is synthetically produced from the 590-640 sequence and is suitable for use in western blot applications. |
Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Gene Symbol: |
SLC9A3 |
Gene ID: |
6550 |
Uniprot ID: |
SL9A3_HUMAN |
Immunogen Region: |
590-640 |
Specificity: |
This blocking peptide is recommended for use in combination with SLC9A3 antibody, STJ506227 |
Immunogen: |
Synthetic peptide corresponding to amino acids within region 590-640 on human SLC9A3 protein. |
Function | Plasma membrane Na(+)/H(+) antiporter. Exchanges intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry, playing a key role in salt and fluid absorption and pH homeostasis. Major apical Na(+)/H(+) exchanger in kidney and intestine playing an important role in renal and intestine Na(+) absorption and blood pressure regulation. |
Peptide Name | Sodium/Hydrogen Exchanger 3Na(+/H(+ Exchanger 3Nhe-3Solute Carrier Family 9 Member 3 |
Database Links | Reactome: R-HSA-425986 |
Cellular Localisation | Apical Cell MembraneMulti-Pass Membrane ProteinCell MembraneRecycling Endosome MembraneEarly Endosome MembraneIn Intestinal Epithelial CellsLocalizes To The Ileal Brush BorderPhosphorylation At Ser-663 By Sgk1 Is Associated With Increased Abundance At The Cell MembraneAngiotensin-2 Enhances Apical Expression |
Alternative Peptide Names | Sodium/Hydrogen Exchanger 3 proteinNa(+/H(+ Exchanger 3 proteinNhe-3 proteinSolute Carrier Family 9 Member 3 proteinSLC9A3 proteinNHE3 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance